Newsroom

Vizient Enhances DataLYNX with Compressed ERP Descriptions, GTINs and Product Attribute Detail
This solution offers users several new tools for more effective item master management.
Blog: Understanding the Potential Impacts of USP <825> for Radiopharmaceutical Compounding
In recent years, there has been a significant amount of regulatory focus on compounding pharmacies.
Vizient Announces 21 New, Renewed or Expanded Member Agreements in Q2 of 2019
The new agreements include academic medical centers, community hospitals, integrated health delivery networks and non-acute health care providers.
Vizient Recognizes Members for Achievements in Supply Chain Savings
Through the Impact Standardization Program, these hospitals streamlined their purchasing practices in designated product categories, earning rebates and in many cases attaining lower pricing from...
Blog: The Tragedy of Sepsis and the Collaborative Work to Combat It
At least 1.7 million adults in America develop sepsis every year and nearly 270,000 die as a result. My friend’s son was one of them.

Press releases

More press releases...

Vizient in the news

"Not So Different": Where Are We Headed With Oncology Biosimilars? Vizient Weighs In
The Center for Biosimilars
9/16/19

Drug Shortages Continue to Burden Healthcare
Managed Healthcare Executive
9/11/19

5 ASC supply chain tips to know
Becker's ASC Review
8/29/19

More in the news...

Blog

More blog posts...

Twitter

Videos

Where to use advanced practice providers in patient care

Industry news

Groupons For Medical Treatment? Welcome To Today’s U.S. Health Care
Kaiser Health News
9/6/19
Push on 'surprise' medical bills hits new roadblocks
The Hill
9/6/19
Multiple sclerosis drug costs skyrocketed for Medicare and patients, study finds
Healthcare Dive
8/28/19

More industry news...

Media contacts and tools

Angie Boliver
972.830.7961
angie.boliver@vizientinc.com

Donna Ledbetter
972.830.6321
donna.ledbetter@vizientinc.com

Nancy Matocha
972.830.9756
nancy.matocha@vizientinc.com

Elida Solis
312.775.4232
elida.solis@vizientinc.com

Connect with us

Subsidiary companies

Provista^TM
aptitude^TM
Sg2